Copyright: ©Author(s) 2026.
World J Diabetes. May 15, 2026; 17(5): 117635
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.117635
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.117635
Table 1 Primer sequences
| Primer name | Primer sequence |
| β-actin | Forward: 5’-TGCTATGTTGCCCTAGACTTCG-3’ |
| Reverse:5’-GTTGGCATAGAGGTCTTTACGG-3’ | |
| GPX4 | Forward: 5’-ATTCCCGAGCCTTTCAACCC-3’ |
| Reverse: 5’-TATCGGGCATGCAGATCGAC-3’ | |
| XCT | Forward: 5’-TATGCTGAATTGGGTACGAGC-3’ |
| Reverse: 5’-TATTACCAGCAGTTCCACCCA-3’ | |
| Nrf2 | Forward: 5’-GACATCCTTTGGAGGCAAGACAT-3’ |
| Reverse: 5’-TGGGAATGTGGGCAACCTG-3’ | |
| HO-1 | Forward: 5’-TAAGACCGCCTTCCTGCTCAA-3’ |
| Reverse: 5’-ACGGTCGCCAACAGGAAACT-3’ |
- Citation: Zhao Y, Feng XZ, Cao WQ, Chen YR, Yang Y, Liu JC, Xu A, Ren YL, Wang ZM. Zuo Gui pill alleviates M1 macrophage polarization in type 2 diabetic osteoporosis through the Nrf2/HO-1/XCT/GPX4 pathway. World J Diabetes 2026; 17(5): 117635
- URL: https://www.wjgnet.com/1948-9358/full/v17/i5/117635.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i5.117635